From human insulin to designer insulin. Why insulin analogs?
Jungmann, E.
Fortschritte der Medizin 115(12): 40-41
1997
ISSN/ISBN: 0015-8178 PMID: 9235302 Document Number: 483500
Document emailed within 1 workday
Related Documents
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Klöppel, G.; Freytag, G.; Graesslin, D. 1973: Preparation of monomer insulin components and insulin-like contaminants from crystalline insulin by isoelectric focusing technique Acta Endocrinologica. Supplementum 173: 58
Chang, T.C.; Wang, L.M.; Cheng, C.Y.; Kuo, H.F.; Liu, P.C.; Ho, L.T. 1990: The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients Zhonghua Yi Xue Za Zhi 46(2): 79-85
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
De Meijer, P.H.; Lutterman, J.A. 1990: Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin Netherlands Journal of Medicine 36(1-2): 4-12
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Hildebrandt, P. 1991: Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors Danish Medical Bulletin 38(4): 337-346
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89
De Meyts, P. 1994: Insulin receptors and mechanism of action of insulin and of insulin-like growth factors Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 149(3-4): 181-190; Discussion: 190-194
Mohan, V.; Das, A.K.; Joshi, S.R. 2015: Insulin Degludec/Insulin Aspart: a Novel Co-formulation for Insulin Intensification Journal of the Association of Physicians of India 63(5 Suppl): 6-7
Okada, Y. 2012: New information of oral insulin, nasal insulin and inhaled insulin Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 678-681
Imachi, H.; Murao, K. 2012: Insulin, glucagon, insulin autoantibody (IAA), insulin receptor antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 442-445
Perelygina, A.A.; Smirnova, O.M.; Lobanova, A.M.; Gorelysheva, V.A. 1988: Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus Problemy Endokrinologii 34(1): 3-5
Würzburger, M.I.; Prelević, G.M.; Despotović, N.; Vucković, S.; Brkić, S.D.; Bozović, M.; Nastić-Mirić, D. 1987: Delayed-type allergy against various insulin preparations including human semisynthetic insulin Annals of Allergy 59(1): 44-47
Rosas Vargas, M.A.; Alvarez Amador, M.; Alvarez Amador, L.M.; del Río Navarro, B.E.; Avila Castanón, L.; Sienra Monge, J.J. 2001: Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus Revista Alergia Mexico 48(5): 129-132
Gatti, A.; Dell'Aversano, R.; Monda, M.; Bonavita, M.; Bocchino, C.; Giacometti, F.; Carleo, R. 1987: Evaluation of the effects of the transition from animal insulin to biosynthetic human insulin Bollettino della Societa Italiana di Biologia Sperimentale 63(7): 597-604; 610-611
Testa, I.; Clementi, M.; Festa, A.; Bagnarelli, P.; Brugia, M.; de Martinis, C. 1985: Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line Developments in Biological Standardization 60: 81-91
Waldhäusl, W.K.; Gasić, S.; Bratusch-Marrain, P.; Korn, A.; Nowotny, P. 1982: Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects American Journal of Physiology 243(6): E476-E482